Powered Research

Executive Summary

Powered Research is a specialized preclinical CRO offering non-GLP testing services in ophthalmology and oncology. Founded in 2017, the company operates a 20,000 sq ft vivarium and 7,000 sq ft wet lab in Boston, enabling rapid study turnaround and custom experimental design. It serves a diverse client base from startups to large pharma, positioning itself as a nimble alternative to larger CROs. The company’s focus on high-growth therapeutic areas and its ability to provide tailored preclinical solutions suggest strong demand for its services. However, being a private, pre-clinical stage company with no disclosed funding or revenues, its growth trajectory is uncertain. The conviction score of 65 reflects a balanced view: the niche focus and facility assets are positives, but the lack of financial transparency and competitive pressures in the CRO market temper enthusiasm.

Upcoming Catalysts (preview)

• Q4 2026Expansion into GLP-compliant testing services40% success
• Q2 2027Major pharmaceutical partnership for oncology preclinical studies50% success